Learn how to exploit advances in exosomes to improve efficiencies in drug delivery by attending next week’s Exosomes Europe event, held 5-6 June 2024 in London. 

Brought to you by the organisers of BioProcess International, our Exosomes Europe event connects you with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization, with a focus on:

  • Reducing your costs and timelines
  • Expanding exosomes therapeutic potential
  • Overcoming complex CMC challenges
Register for the event

Featured Speakers

Kuniko Kadoya
Director / Research Fellow
Allergan Aesthetics/AbbVie

Presentation: Fibroblast Derived Exosomes are Key Component of Skin Rejuvenation

Spencer Marsh
Chief Scientific Officer
Tiny Cargo Company

Presentation: Industrial Purification of Milk Derived Extracellular Vesicles

Mafalda Cacciottolo
Associate Director of R&PD
Capricor Therapeutics, Inc.

Keynote: Discussing the Advantages of Engineered vs Naturally Derived Exosomes

Christopher Locher
CEO & Co-Founder
Versatope Therapeutics

Keynote: Extracellular Transport Vesicles for Cell-specific Cargo Delivery and Vaccines